All chemicals, unless otherwise specified, were obtained from Sigma (St. Louis, MO) or Fisher Scientific (Hampton, NH). Fe(III)-incorporated non-native heme cofactors were purchased from Frontier Scientific (Logan, UT).
Fe(III)-2,4-diacetyl deuteroporphyrin IX chloride (DA-heme), Fe(III)-2,4 (4,2) formyl vinyl deuteroporphyrin IX chloride (MF-heme) and Fe(III)-2,4-diformyl deuteroporphyrin IX chloride (DF-heme) were characterized by mass spectrometry before being incorporated into the apo-protein. The non-native heme cofactors were dissolved in dimethyl sulfoxide and titrated into the apo-WTMb/apo-F33Y-CuBMb until the ratio of the absorption of the heme band (408-430 nm depending on the cofactor) to that of the protein (280 nm) stopped increasing (usually 3 equivalent of heme was added to the apo-protein). Heme-protein mixture was then dialyzed against subsequently increasing concentration of pH 7 potassium phosphate buffers to ensure proper folding of the protein. The excess heme was then removed by a DEAE-Sepharose and size exclusion column. F33Y-CuBMb variants were finally chelexed to remove any metal ions at the CuB site as per a procedure reported previously. 2, 4 
Characterization of F33Y-CuBMb and WTMb variants via UV-vis spectroscopy and

Circular Dichroism
Table S1 enlists the spectral features of oxidized and reduced forms of F33Y-CuBMb and WTMb variants. The oxidized form of the proteins show a Soret band at 400 nm range followed by  and  bands in the visible region, typical of a well-folded oxidized myoglobin. Extinction coefficient of the proteins was determined by hemochromogen assay where the wavelength maximum (in nm) and extinction coefficient (in mM -1 cm -1 ) used for the  peak of heme b, DA-, MF-and DF-heme were 556 (36), 576 (25), 583 (28) and 587 (20.5) respectively. Even though a racemic mixture of Fe(III)-2,4 (4,2)formyl vinyl deuteroporphyrin IX chloride (MF-heme) was titrated into the apo-F33Y-CuBMb, comparison of the UV-vis spectroscopic properties of F33Y-CuBMb (MF-heme) (e.g. Soret wavelength maxima and the wavelength maxima of the hemochromogenic assay) with literature values reveals that only Fe(III)-2,4-formyl vinyl deuteroporphyrin IX got incorporated in the protein. 5, 6 It should be noted that the wavelength maxima of MF-heme and DF-heme in the hemochromogenic assay exhibit a bathochromic shift as compared to heme b and match well with that of native heme a in the catalytic site of cytochrome c oxidase (585 nm). 7
S3
Circular dichroism (CD) measurements as a function of wavelength were obtained using a JASCO J-715 spectrometer at 20°C in a standard 1 cm path length cuvette with protein samples in 100 mM phosphate buffer pH 6.0 at a protein concentration of 2-3 M. The Mean Residue Ellipticities [Ɵ]222nm was calculated with the following equation :
Helical content of the protein was determined as described by Chen et al, and compared to the literature record of WTMb. 8, 9 L: length of light path of cuvette; C: protein sample concentration; n: total number of the amino acid residues in the protein.
Spectroelectrochemical Measurements
The reduction potential (E°) was measured by a spectroelectrochemical method using an optically transparent thin-layer cell increments), the UV-vis spectra were recorded using a Cary 3E spectrophotometer until no further spectral changes occurred. The Ag/AgCl (3M KCl) reference electrode was calibrated using ferrocene carboxylic acid as the standard and was found to be 220 mV versus SHE. All reduction potentials mentioned in this work are reported against SHE.
The system was calibrated using WTMb (Fig. S4 ); the measured Eº of 61 ± 2 mV matched closely to reported literature values. 10, 11 S4
Data Analysis for spectroelectrochemical measurements
The spectroelectrochemical titration data over the entire spectra were analyzed by global analysis using singular value decomposition (SVD) and nonlinear regression modeling with SpecFit/32 (Spectrum Software Associates, Inc.) using a method followed previously. [12] [13] [14] All of the data were fit with a model of A ↔ B as the Nernst plot at a single wavelength gave a straight line fit with n (no. of electrons transferred) value close to 1.
Oxygen consumption assay and Turnover studies using an Oxygen Electrode.
The rate of water and ROS production was measured and calculated as reported previously with slight modifications. 1 6 M of protein was incubated in air saturated 100 mM phosphate buffer at pH 6. The oxygen consumption assay was initiated by the addition of 10 mM ascorbate and 1 mM of TMPD.
To calculate the percentage of water with respect to O2and H2O2 (ROS) formation, we repeated the measurement of O2 reduction in the presence of superoxide dismutase (SOD) (250 units) and catalase (2.2 M), which selectively react with O2and H2O2, respectively. By comparing the rates of reduction in the absence of and in the presence of SOD and catalase, the portion of O2 reduction that is due to H2O formation can be calculated, using a protocol reported previously. 1 To investigate if TMPD is required for O2 reduction experiments, we measured O2 reduction rates of F33Y-CuBMb and its variants by ascorbate in the absence of TMPD (Fig. S6) . The O2 reduction rates of F33Y-CuBMb, F33Y-CuBMb (MF-heme) and F33Y-CuBMb (DF-heme) are much lower than those in the presence of TMPD. Interestingly, even in the absence of TMPD, the rate of O2 reduction increases in direct correlation with heme Eº. Therefore, our results are consistent with the hypothesis that TMPD is a redox mediator to help ascorbate reduce the proteins more efficiently. 15 The turnover experiment in Fig. 4B was performed similarly except that after the O2 in the reaction chamber was exhausted, the chamber was vented with pure O2 to boost O2 concentration to 500-600 M. The concentration of ascorbate was kept at 10 mM. 
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